Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 16.61
+0.09 (0.54%)
Jun 9, 2026, 3:04 PM CST
SHE:000623 Revenue
Jilin Aodong Pharmaceutical Group had revenue of 514.09M CNY in the quarter ending March 31, 2026, a decrease of -17.43%. This brings the company's revenue in the last twelve months to 2.23B, down -6.12% year-over-year. In the year 2025, Jilin Aodong Pharmaceutical Group had annual revenue of 2.34B, down -10.55%.
Revenue (ttm)
2.23B
Revenue Growth
-6.12%
P/S Ratio
8.75
Revenue / Employee
407.74K
Employees
5,461
Market Cap
19.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.34B | -275.38M | -10.55% |
| Dec 31, 2024 | 2.61B | -838.55M | -24.31% |
| Dec 31, 2023 | 3.45B | 580.91M | 20.25% |
| Jan 1, 2023 | 2.87B | 564.45M | 24.50% |
| Jan 1, 2022 | 2.30B | 52.11M | 2.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition